These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 6792911)

  • 21. Calcium and phosphorus compatibility in parental nutrition solutions for neonates.
    Eggert LD; Rusho WJ; MacKay MW; Chan GM
    Am J Hosp Pharm; 1982 Jan; 39(1):49-53. PubMed ID: 6798868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration.
    Joy J; Silvestri AP; Franke R; Bistrian BR; Nehne J; Newton DW; Driscoll DF
    JPEN J Parenter Enteral Nutr; 2010; 34(1):46-54. PubMed ID: 19846668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of particles in intravenous fluids using scanning electron microscopy.
    Levinson RS; Allen LV; Stanaszek WF; Mills S
    Am J Hosp Pharm; 1975 Nov; 32(11):1137-41. PubMed ID: 1190235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF.
    Fitzgerald KA; MacKay MW
    Am J Hosp Pharm; 1987 Jun; 44(6):1396-400. PubMed ID: 3113238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Particulate contamination of infusion solutions and drug additives within the scope of long-term intensive therapy. 1. Energy dispersion electron images in the scanning electron microscope-REM/EDX].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Anaesthesist; 1989 Oct; 38(10):544-8. PubMed ID: 2511778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical compatibility of neonatal total parenteral nutrition admixtures containing organic calcium and inorganic phosphate salts in a simulated infusion at 37 degrees C.
    Singh H; Dumas GJ; Silvestri AP; Young S; Martin CR; Bistrian BR; Driscoll DF
    Pediatr Crit Care Med; 2009 Mar; 10(2):213-6. PubMed ID: 19188866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium and phosphate solubility curves for parenteral nutrient solutions containing Vaminolact.
    Mo-Suwan L; Puetpaiboon A; Apiromrak B
    J Med Assoc Thai; 1997 Aug; 80(8):516-20. PubMed ID: 9277084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of amino acids and the availability of acid in total parenteral nutrition solutions containing hydrochloric acid.
    Mirtallo JM; Rogers KR; Johnson JA; Fabri PJ; Schneider PJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1729-31. PubMed ID: 6795923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particulate matter in parenteral products: a review.
    Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD
    J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253
    [No Abstract]   [Full Text] [Related]  

  • 30. A strategy for reducing particulate contamination on opening glass ampoules and development of evaluation methods for its application.
    Lee KR; Chae YJ; Cho SE; Chung SJ
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1394-401. PubMed ID: 21702739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quantitative analysis of particulate matter in infusion solutions, administration sets and additives (author's transl)].
    Ahnefeld FW; Klaus E
    Anaesthesist; 1977 Aug; 26(8):476-84. PubMed ID: 907081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Particulate contamination in parenterals: current issues.
    Groves MJ
    Boll Chim Farm; 1991 Oct; 130(9):347-54. PubMed ID: 1799429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined scanning electron microscopy and image analysis to investigate airborne submicron particles: a comparison between personal samplers.
    Zamengo L; Barbiero N; Gregio M; Orrù G
    Chemosphere; 2009 Jul; 76(3):313-23. PubMed ID: 19398120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of retrograde aminophylline administration on calcium and phosphate solubility in neonatal total parenteral nutrient solutions.
    Kirkpatrick AE; Holcombe BJ; Sawyer WT
    Am J Hosp Pharm; 1989 Dec; 46(12):2496-500. PubMed ID: 2513716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Particulate contamination in parenteral nutrition solutions: still a cause for concern?
    Ball PA; Bethune K; Fox J; Ledger R; Barnett M
    Nutrition; 2001; 17(11-12):926-9. PubMed ID: 11744342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products.
    Tsuji K; Lewis AR
    J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Particulate-matter content of D5/NS for injection: manufacturer difference and conformance with USP limits.
    Smith JK; Baumann RR; Gunning WT; Annancy L; Alexander KS
    J Parenter Sci Technol; 1988; 42(6):180-6. PubMed ID: 3273493
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth of bacteria and fungi in parenteral nutrition solutions containing albumin.
    Mirtallo JM; Caryer K; Schneider PJ; Ayers L; Fabri PJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1907-10. PubMed ID: 6798862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the particulate content of LVP using different test methods. Health Industry Manufacturer's Association.
    J Parenter Sci Technol; 1989; 43(5):200-3. PubMed ID: 2809926
    [No Abstract]   [Full Text] [Related]  

  • 40. Compatibility of calcium chloride and calcium gluconate with sodium phosphate in a mixed TPN solution.
    Henry RS; Jurgens RW; Sturgeon R; Athanikar N; Welco A; Van Leuven M
    Am J Hosp Pharm; 1980 May; 37(5):673-4. PubMed ID: 6770681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.